Sign in
XAGE Stock Price, Chart, Stats & News
Longevity Health Holdings Inc.
Save
Longevity Health Holdings Inc. (XAGE) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
XAGE chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 54.63% |
Operating margin | -400.96% |
Pretax margin | -400.30% |
Net margin | -393.63% |
Effective tax rate | 1.67% |
ROA | -173.88% |
ROE | 141.35% |
D/E | -0.16x |
Interest coverage ratio | -290.33x |
XAGE valuation
P/E | – |
P/S | 0.31x |
P/B | -0.13x |
P/CF | -0.14x |
P/FCF | -0.12x |
P/OCF | -0.14x |
PEG | 0.00x |
EV multiple | -0.17x |
About
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such as tibia fracture recovery, foot/ankle and spinal fusions, serving as a dental bone graft substitute, and filling bone voids. Additionally, CT-101 functions as a tissue healing accelerant, offering potential for treating androgenetic alopecia and persistent chronic wounds.
Similar securities
Based on sector and market capitalization
Report issue